Opko Health Inc [NASDAQ: OPK] gained 4.10% or 0.05 points to close at $1.27 with a heavy trading volume of 5331896 shares. The daily chart for OPK points out that the company has recorded 3.25% gains over the past six months. If we look at
Opko Health Inc [NASDAQ: OPK] slipped around -0.02 points on Wednesday, while shares priced at $1.23 at the close of the session, down -1.60%. Compared to the average trading volume of 9.20M shares, OPK reached a trading volume of 6062915 in the most recent trading
Opko Health Inc [NASDAQ: OPK] slipped around -0.02 points on Tuesday, while shares priced at $1.21 at the close of the session, down -1.63%. Compared to the average trading volume of 9.58M shares, OPK reached a trading volume of 4050594 in the most recent trading
Opko Health Inc [NASDAQ: OPK] jumped around 0.05 points on Monday, while shares priced at $1.40 at the close of the session, up 3.70%. The company report on March 28, 2024 at 8:00 AM that Labcorp Announces Acquisition of Select Assets of BioReference Health’s Diagnostics
Opko Health Inc [NASDAQ: OPK] surged by $0.13 during the normal trading session on while it closed the day at $1.20. The company report on March 28, 2024 at 8:00 AM that Labcorp Announces Acquisition of Select Assets of BioReference Health’s Diagnostics Business. Transaction to
Opko Health Inc [NASDAQ: OPK] closed the trading session at $1.01. The company report on March 20, 2024 at 8:00 AM that Entera Bio Announces Robust Pharmacokinetic Data for First-in-Class Oral GLP-2 Peptide Tablet Treatment for Patients with Short Bowel Syndrome. Pharmacokinetic Profile of Oral
Opko Health Inc [NASDAQ: OPK] surged by $0.03 during the normal trading session on while it closed the day at $0.96. The company report on March 20, 2024 at 8:00 AM that Entera Bio Announces Robust Pharmacokinetic Data for First-in-Class Oral GLP-2 Peptide Tablet Treatment
Opko Health Inc [NASDAQ: OPK] slipped around -0.02 points on Monday, while shares priced at $0.87 at the close of the session, down -3.27%. Compared to the average trading volume of 12.99M shares, OPK reached a trading volume of 10674627 in the most recent trading
Opko Health Inc [NASDAQ: OPK] loss -1.63% on the last trading session, reaching $0.94 price per share at the time. The company report on March 5, 2024 at 8:52 AM that AIDS Clinical Trial Group Presents Results from Phase 1 Study of ModeX Trispecific Antibody
Opko Health Inc [NASDAQ: OPK] price plunged by -6.51 percent to reach at -$0.07. The company report on March 5, 2024 at 8:52 AM that AIDS Clinical Trial Group Presents Results from Phase 1 Study of ModeX Trispecific Antibody for the Treatment and Prevention of
© 2024, Powered by Smart TechOne
